ESR1 and metabolic dysfunction-associated steatotic liver disease: With respect to patients with simple steatosis, hepatic ERα expression is lower in the liver of patients with NASH, suggesting that this receptor plays a specific role in counteracting pro-inflammatory and pro-apoptotic processes that can favor NAFLD progression and liver degeneration [398].